Literature DB >> 404411

Heterozygote detection in angiokeratoma corporis diffusum (Anderson-Fabry disease). Studies on plasma, leucocytes, and hair follicles.

M W Spence, A L Goldbloom, J K Burgess, D D'entremont, B A Ripley, K L Weldon.   

Abstract

Heterozygote detection for angiokeratoma corporis diffusum (Anderson-Fabry disease, ACD), an X-linked disorder of glycosphingolipid metabolism was examined using alpha-galactosidase activity, an alpha-galactosidase/beta-galactosidase activity ratios (alpha/beta ratio) in leucocytes, plasma, and hair follicles; For leucocytes, 22 obligate heterozygotes, 25 suspected heterozygotes, and 47 control subjects were studied, while for plasma, the groups were 17 obligate heterozygotes and 35 controls. The alpha/beta ratio in plasma and leucocytes was clearly a better discriminator between obligate heterozygotes and controls than alpha-galactosidase activity alone, but still failed to detect 3 obligates with leucocytes and 2 with plasma. Discrimination was not improved by joint use of plasma and leucocyte alpha/beta ratios, but was improved by measurement of hair-follicle alpha/beta ratios. The interdecile range of log (alpha-galactosidase/beta-galactosidase activity) in 20 hair follicles from each of 4 obligate and 7 suspected heterozygotes was clearly different from 11 control subjects. Accordingly, for rapid screening for carriers of ACD, we recommend use of leucocyte or plasma alpha/beta ratios which should detect greater than 85% of heterozygotes. When results are equivocal, and ancillary information suggests heterozygous status, the more time-consuming measurement of hair-follicle alpha/beta ratios is a useful additional test.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 404411      PMCID: PMC1013521          DOI: 10.1136/jmg.14.2.91

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  30 in total

1.  Substrate specificity of ceramide trihexosidase.

Authors:  C A. Mapes; C C. Sweeley
Journal:  FEBS Lett       Date:  1972-09-15       Impact factor: 4.124

2.  Preparation and properties of an affinity column adsorbent for differentiation of multiple forms of -galactosidase activity.

Authors:  C A Mapes; C C Sweeley
Journal:  J Biol Chem       Date:  1973-04-10       Impact factor: 5.157

3.  Fabry's disease: normal alpha-galactosidase activity and urinary-sediment glycosphingolipid levels in two obligate heterozygotes.

Authors:  J L Avila; J Convit; G Velazquez-Avila
Journal:  Br J Dermatol       Date:  1973-08       Impact factor: 9.302

4.  Detection of Fabry hemizygotes and heterozygotes by measurement of -galactosidase in urine.

Authors:  P J Rietra; J M Tager; W P de Groot
Journal:  Clin Chim Acta       Date:  1972-08       Impact factor: 3.786

5.  Fabry's disease: evidence for a physically altered -galactosidase.

Authors:  M W Ho; S Beutler; L Tennant; J S O'Brien
Journal:  Am J Hum Genet       Date:  1972-05       Impact factor: 11.025

6.  Fabry's disease: absence of an -galactosidase isozyme.

Authors:  S Wood; H L Nadler
Journal:  Am J Hum Genet       Date:  1972-05       Impact factor: 11.025

7.  Enzymatic defect in Fabry's disease. Ceramidetrihexosidase deficiency.

Authors:  R O Brady; A E Gal; R M Bradley; E Martensson; A L Warshaw; L Laster
Journal:  N Engl J Med       Date:  1967-05-25       Impact factor: 91.245

8.  Detection of glucose-6-phosphate dehydrogenase deficient heterozygotes.

Authors:  G Stamatoyannopoulos; T Papayannopoulou; C Bakopoulos; A G Motulsky
Journal:  Blood       Date:  1967-01       Impact factor: 22.113

9.  Galactosylgalactosylglucosylceramide: Galactosyl hydrolase in normal human plasma and its absence in patients with fabry's disease.

Authors:  C A. Mapes; R L. Anderson; C C. Sweeley
Journal:  FEBS Lett       Date:  1970-04-02       Impact factor: 4.124

10.  Fabry's disease: alpha-galactosidase deficiency.

Authors:  J A Kint
Journal:  Science       Date:  1970-02-27       Impact factor: 47.728

View more
  12 in total

Review 1.  Basic findings and current developments in sphingolipidoses.

Authors:  H Pilz; R Heipertz; D Seidel
Journal:  Hum Genet       Date:  1979-03-12       Impact factor: 4.132

2.  Iduronate sulfatase analysis of hair roots for identification of Hunter syndrome heterozygotes.

Authors:  T Yutaka; A L Fluharty; R L Stevens; H Kihara
Journal:  Am J Hum Genet       Date:  1978-11       Impact factor: 11.025

3.  Anderson-Fabry disease: rapid detection of carriers by hair bulb analysis.

Authors:  A Ejiofor; D Robinson; D Wise; M Hamers; J M Tager
Journal:  J Inherit Metab Dis       Date:  1978       Impact factor: 4.982

4.  Fabry disease in a large Nova Scotia kindred: carrier detection using leucocyte alpha-galactosidase activity and an NcoI polymorphism detected by an alpha-galactosidase cDNA clone.

Authors:  A J Kirkilionis; D C Riddell; M W Spence; R G Fenwick
Journal:  J Med Genet       Date:  1991-04       Impact factor: 6.318

5.  Uneven X inactivation in a female monozygotic twin pair with Fabry disease and discordant expression of a novel mutation in the alpha-galactosidase A gene.

Authors:  I Redonnet-Vernhet; J K Ploos van Amstel; R P Jansen; R A Wevers; R Salvayre; T Levade
Journal:  J Med Genet       Date:  1996-08       Impact factor: 6.318

6.  Angiokeratoma corporis diffusum (Anderson-Fabry disease) in a single large family in Nova Scotia.

Authors:  M W Spence; J T Clarke; D M D'Entremont; G A Sapp; E R Smith; A L Goldbloom; G Davar
Journal:  J Med Genet       Date:  1978-12       Impact factor: 6.318

7.  Hair root diagnosis of Fabry's disease.

Authors:  D Robinson; J M Tager
Journal:  J Inherit Metab Dis       Date:  1989       Impact factor: 4.982

8.  Fibroblast alpha-galactosidase A activity for identification of Fabry's disease heterozygotes.

Authors:  A H Fensom; P F Benson; A R Grant; L Jacobs
Journal:  J Inherit Metab Dis       Date:  1980       Impact factor: 4.982

9.  Progress in screening for inborn errors of metabolism.

Authors:  R W Watts
Journal:  Experientia       Date:  1978-02-15

10.  Anderson Fabry disease, a close linkage with highly polymorphic DNA markers DXS17, DXS87 and DXS88.

Authors:  K D MacDermot; S H Morgan; J K Cheshire; T M Wilson
Journal:  Hum Genet       Date:  1987-11       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.